- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
622 |
30 Hydrocolpos, Vaginal Agenesis and Atresia |
|
|
•Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome
–Proximal vaginal atresia
–Distal vaginal atresia
30.5Associated Anomalies
•Vagina atresia and agenesis are congenital anomalies of the female genitourinary tract and may occur as:
•An isolated developmental defect
•Part of a complex of developmental anomalies such as:
–The Rokitansky-Mayer-Küster-Hauser (RMKH) syndrome
–The Bardet-Biedl syndrome
–The Kaufman-McKusick syndrome
–The Fraser syndrome
–The Winters syndrome.
•Renal anomalies:
–Occur in 30 % of patients with RMKH syndrome.
–These anomalies include:
•Unilateral agenesis of the kidney
•Ectopic kidneys
•Horseshoe kidney
•Crossed-fused renal ectopia
•Skeletal anomalies:
–Fused vertebrae
–Anomalies of the ribs and limbs
30.6Embryology
•Normally there are two pairs of ducts in the embryo, the wollfian and Mullerian ducts.
•These are responsible for the development of the male (Wollfian) and female (Mullerian) internal genitalia.
•In the female embryo:
–The absence of testes which secret testesterone and Mullerian inhibiting substance (MIS) allow development and differentiation of the müllerian duct system and regression of the wolffian ducts.
–The müllerian duct elongate and reaches the urogenital sinus by 9 weeks’ gestation, and form the uterovaginal canal.
–The two müllerian ducts proceed caudad to cephalad and fuse together to form the uterine cavity and upper two thirds of the vagina.
–The fallopian tubes are formed from the cephalic remnants of the müllerian duct.
–The sinovaginal bulbs form as bilateral endodermal invaginations.
–Cephalic growth of the sinovaginal bulb and their fusion with the vaginal cord forms the vaginal plate.
–Canalization of the uterovaginal canal is believed to occur from the caudal to the cephalic aspect, with an epithelial lining derived from the urogenital sinus.
– Vaginal development is completed by 5 months’ gestation and their musculature is derived from surrounding mesenchyme.
–The vagina is embryologically derived from both the müllerian ducts and the urogenital sinus.
–It is postulated that the upper two thirds of the vagina are derived from the mullerian ducts and the lower third is derived from the urogenital sinus.
•Failure of this normal development at any stage can lead to genital abnormalites:
–Persistent Mullerian duct syndrome: This is seen in male children as a result of failure of secretion of MIS or failure of the receptors to respond to MIS. It is characterized by the presence of a uterus, upper part of vagina and fallopian tubes in a phenotypically and genetically normal male.
–A septate uterus: This results from failure of the septum between the two mullerian ducts to regress.
–Arcuate, bicornuate, or didelphic uteri: These result from incomplete fusion of the müllerian ducts.
–Uterovaginal atresia: This results from failure of the caudal development of the müllerian ducts.
–A transverse vaginal septum: This results from failures at the level of the vaginal plate.
–Vaginal atresia: This occurs when the caudal portion of the vagina, contributed by the urogenital sinus, fails to form. This cau-
30.7 Clinical Features |
623 |
|
|
dal portion of the vagina is replaced with fibrous tissue.
–Lower vaginal atresia is a type of vagina atresia where the lower 3rd of the vagina fails to develop.
–It is usually not considered a type of Mullerian duct anomaly. It occurs from a failure of recanalisation of the urogenital sinus.
–Patients with RMKH syndrome and vaginal atresia are phenotypically and genotypically female with a 46, XX karyotype. However, a familial association suggests autosomal dominant transmission of a mutant gene by male relatives.
–Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is defined as Müllerian aplasia with vaginal agenesis and uterine remnants.
–It is commonly associated with renal and sometimes vertebral anomalies. The MRKH syndrome or distal vaginal atresia is sometimes associated with anorectal malformations.
30.7Clinical Features
Fig. 30.5 A clinical photograph showing a newborn with abdominal mass secondary to hydrometrocolpos
•The clinical presentation of vaginal atresia is variable.
•The majority of neonates with vaginal atresia are asymptomatic but they my present with:
–An abdominal mass (Figs. 30.5 and 30.6):
•This is secondary to hydrocolpos or hydrometrocolpos.
•It may be discovered during routine antenatal ultrasound
•This may be discovered clinically immediately after delivery or during the first few weeks of life.
–Sepsis
–Respiratory distress.
•Vaginal atresia may remain asymptomatic till adolescence and the presentation may include:
–Amenorrhea
–Cyclical abdominal pain
–Difficulty in voiding
–An abdominopelvic mass
–Backache
•The presence of polydactly and congenital heart disease is suggestive of an associated
Fig. 30.6 A clinical photograph showing a newborn with abdominal mass secondary to hydrometrocolpos. The mass is arising from the pelvis upwards
syndrome (McKusick-Kaufman syndrome, Bardet-Biedl syndrome). The polydactly can affect either lower and upper limbs or only one limb (Figs. 30.7, 30.8, 30.9, and 30.10).
•Perineal examination may reveal:
–Normal external genitalia
–No apparent vaginal orifice and no hymen
–Development of secondary sex characteristics in the adolescent.
–An isolated vaginal dimple or a small vaginal pouch with a normal hymenal ring may be seen.
–Abnormal anal opening (Figs. 30.11 and 30.12)
–Labial fusion may obscure the anatomy of some patients and be confused with vaginal atresia.
–The presence of posterior labial fusion and enlarged clitoris is suggestive of congenital adrenal hyperplasia.
624 |
30 Hydrocolpos, Vaginal Agenesis and Atresia |
|
|
Figs. 30.7, 30.8, 30.9, and 30.10 Clinical photographs showing polydactly both upper and lower limbs
Figs. 30.11 and 30.12 Clinical photographs showing a newborn with vaginal atresia. Note the absence of a vaginal opening. Note also the anteriorly placed anus in the first picture
30.8 Investigations |
625 |
|
|
•McKusick-Kaufman syndrome:
–This is an autosomal recessive disorder.
–It is characterized by:
•Hydrometrocolpos secondary to vaginal atresia.
•Postaxial polydactyly
•Imperforated anus
•Congenital heart defects.
•Bardet-Biedl syndrome:
–This is an autosomal recessive disorders.
–It is characterized by:
•Vaginal atresia
•Retinal dystrophy or retinitis pigmentosa
•Postaxial polydactyly
•Obesity
•Nephropathy
•Mental disturbances
•Fraser syndrome:
–Fraser syndrome (also known as MeyerSchwickerath’s syndrome, Fraser-François syndrome, or Ullrich-Feichtiger syndrome) is an autosomal recessive congenital disorder.
–It is characterized by:
•Cryptophthalmos (where the eyelids fail to separate in each eye)
•Vaginal atresia
•Other malformations of the genitalia including micropenis, and cryptorchidism in males and clitoromegaly in females.
•Congenital malformations of the nose, ears, larynx and renal system.
•Mental retardation
•Syndactly
•Winters syndrome:
–It is characterized by ear anomalies and vaginal atresia.
30.8Investigations
•In newborns, it is important to define preoperatively the anatomic abnormality leading to the hydrometrocolpos.
•Whereas imperforate hymen is clinically evident and simple to treat, vaginal atresia is more complex to define and manage.
•Abdominal radiograph (Figs. 30.13 and 30.14):
–This may reveal a soft tissue density pushing the bowel to the side and upwards.
Figs. 30.13 and 30.14 Abdominal x-rays showing a soft tissue mass representing the dilated vagina and pushing the bowel upwards
626 |
30 Hydrocolpos, Vaginal Agenesis and Atresia |
|
|
Fig. 30.15 Abdominal ultrasound showing a dilated vagina (hydrocolpos) secondary to vaginal atresia
Figs. 30.17 and 30.18 Abdominal CT-scan showing hydrometrocolpos secondary to vaginal atresia
DILATED
UTERUS
DILATED
VAGINA
Fig. 30.16 Abdominal CT-scan showing a very large hydrocolpos
DILATED
UTERUS
DILATED
VAGINA
• Abdominal and pelvic ultrasonography |
– The presence of hydrocolpos or hydrometro- |
(Fig. 30.15): |
colpos can be detected easily with ultrasound. |
– This is a simple, non-invasive investigation |
– It is also useful to evaluate the kidneys, ureter |
for patients with suspected vaginal atresia. |
and urinary bladder and associated anomalies. |
– It is valuable to define the ovaries, uterus, |
• Abdominal and pelvic CT-scan (Figs. 30.16, |
and proximal vagina. |
30.17, 30.18, 30.19, and 30.20): |
30.8 Investigations |
627 |
|
|
Figs. 30.19 and 30.20 Abdominal CT-scan showing hydronephrosis secondary to pressure from the dilated vagina
Fig. 30.21 Intravenous urography showing dilated ureters and hydronephrosis secondary to pressure from hydrometrocolpos
–This gives more detailed information regarding the anatomy and etiology.
•Intravenous urography is rarely used (Fig. 30.21).
•MRI (Figs. 30.22, 30.23, and 30.24):
–This has been reported to be more valuable than ultrasound and CT-scan in delineating the vaginal anatomical defect and the associated hydroureter and hydronephrosis.
•Genitography is an unnecessary invasive investigation that may be harmful leading to secondary infection with subsequent pyometrocolpos (Figs. 30.25 and 30.26).
•This must be kept in mind when evaluating hydrometrocolpos as there is a possibility of secondary infection and development of pyometrocolpos which is a serious complication.
•Laparoscopy may be necessary to evaluate the
uterus and adnexal structures if they are not Fig. 30.22 Abdominal MRI showing a very large
clearly identified on ultrasound, CT-scan or MRI. hydrocolpos